Comparison of Single-Agent Carboplatin vs the Combination of Carboplatin and Everolimus for the Treatment of Advanced Triple-Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Everolimus
Related studies linked through entity extraction aliases.
Combination of Letrozole, Everolimus and TRC105 in Postmenopausal Women With Hormone-Receptor Positive and Her2 Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Maintenance Aromatase Inhibitors (AIs)+ Everolimus vs AIs in Hormone Receptor Positive Metastatic Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE3
Everolimus Therapy in People With Birt-Hogg-Dube Syndrome (BHD)-Associated Kidney Cancer or Sporadic Chromophobe Renal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Effects of Everolimus in Left Ventricular Hypertrophy After Conversion From Azathioprine: A Pilot Study
- Status
- UNKNOWN
- Phase
- PHASE4
Liposomal Doxorubicin, Bevacizumab, and Everolimus in Patients With Locally Advanced TNBC With Tumors Predicted Insensitive to Standard Chemotherapy; A Moonshot Initiative
- Status
- COMPLETED
- Phase
- PHASE2
Study of Lenvatinib in Combination With Everolimus in Participants With Unresectable Advanced or Metastatic Renal Cell Carcinoma (RCC)
- Status
- COMPLETED
- Phase
- PHASE1
A Pilot Study To Evaluate The Effects of Everolimus on Brain mTOR Activity and Cortical Hyperexcitability in TSC and FCD
- Status
- COMPLETED
- Phase
- PHASE2
Etiology of the Platelet-Cancer Metastatic Pathway - A Study of Inflammatory Markers, Platelet Characteristics and Metastatic Surrogates in Cancer Patients and Controls
- Status
- UNKNOWN
- Phase
- NA
Study to Evaluate the Safety and Efficacy of Everolimus, in Subjects With PIK3CA Amplification, PTEN Loss and PIK3CA Mutation Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Durability of Sirolimus for Treatment of LAM
- Status
- RECRUITING
- Phase
- N/A
Impact of Everolimus on HIV Persistence Post Kidney or Liver Transplant
- Status
- COMPLETED
- Phase
- PHASE4
Phase I Trial of VS-6766 Alone and in Combination With Everolimus
- Status
- COMPLETED
- Phase
- PHASE1
Fulvestrant and EVerolimus Plus EXemestane in Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Evaluation of Oral Care to Prevent Oral Mucositis in ER Positive MBC Patients Treated With Everolimus: Phase 3 RCT
- Status
- COMPLETED
- Phase
- PHASE3
Everolimus in Patients With Advanced Solid Malignancies With TSC1, TSC2, NF1, NF2, or STK11 Mutations
- Status
- COMPLETED
- Phase
- PHASE2
Long-term Monitoring of Growth and Development of Pediatric Patients Previously Treated With Everolimus
- Status
- COMPLETED
- Phase
- PHASE4
Outcome-related Factors in Patients With Metastatic Renal Cell Carcinoma Treated With Everolimus (ORCHIDEE)
- Status
- TERMINATED
- Phase
- PHASE4
Study Evaluating the Benefit of Two Immunosuppressive Strategies on Renal Function
- Status
- COMPLETED
- Phase
- PHASE3